293 related articles for article (PubMed ID: 17054030)
1. [Long QT syndrome due to olanzapine administration].
Janion M; Dudek A; Sielski J; Janion-Sadowska A
Kardiol Pol; 2006 Sep; 64(9):986-8. PubMed ID: 17054030
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study.
Watanabe J; Suzuki Y; Fukui N; Ono S; Sugai T; Tsuneyama N; Someya T
J Clin Psychopharmacol; 2012 Feb; 32(1):18-22. PubMed ID: 22198445
[TBL] [Abstract][Full Text] [Related]
3. Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychotics.
Czekalla J; Kollack-Walker S; Beasley CM
J Clin Psychiatry; 2001; 62 Suppl 2():35-40. PubMed ID: 11232751
[TBL] [Abstract][Full Text] [Related]
4. [Drug induced QT prolongation].
Altmann D; Eggmann U; Ammann P
Wien Klin Wochenschr; 2008; 120(5-6):128-35. PubMed ID: 18365152
[TBL] [Abstract][Full Text] [Related]
5. [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia].
Gury C; Canceil O; Iaria P
Encephale; 2000; 26(6):62-72. PubMed ID: 11217540
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic agents associated with QT interval prolongation.
Olsen KM
J Fam Pract; 2005 Jun; Suppl():S8-S14. PubMed ID: 15938993
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced QT prolongation and sudden death.
Del Rosario ME; Weachter R; Flaker GC
Mo Med; 2010; 107(1):53-8. PubMed ID: 20222297
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.
Glassman AH; Bigger JT
Am J Psychiatry; 2001 Nov; 158(11):1774-82. PubMed ID: 11691681
[TBL] [Abstract][Full Text] [Related]
9. [Lengthening of QT interval by antipsychotic drugs].
Haverkamp W; Deuschle M
Nervenarzt; 2006 Mar; 77(3):276, 278-80, 282-4 passim. PubMed ID: 16052325
[TBL] [Abstract][Full Text] [Related]
10. Sulpiride induced torsade de pointes.
Huang BH; Hsia CP; Chen CY
Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic drugs and QT interval prolongation.
Zareba W; Lin DA
Psychiatr Q; 2003; 74(3):291-306. PubMed ID: 12918603
[TBL] [Abstract][Full Text] [Related]
12. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
[TBL] [Abstract][Full Text] [Related]
13. Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.
Berling I; Isbister GK
Ann Emerg Med; 2015 Aug; 66(2):154-64. PubMed ID: 25639523
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
[TBL] [Abstract][Full Text] [Related]
15. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
[TBL] [Abstract][Full Text] [Related]
16. [QT prolongation and second-generation antipsychotics: overdose and therapeutic dosage].
Trojak B; Pinoit JM; Disson-Dautriche A; Bonin B; Giusselmann A
Therapie; 2004; 59(5):558-61. PubMed ID: 15648310
[No Abstract] [Full Text] [Related]
17. Ziprasidone in the management of schizophrenia : the QT interval issue in context.
Taylor D
CNS Drugs; 2003; 17(6):423-30. PubMed ID: 12697001
[TBL] [Abstract][Full Text] [Related]
18. Droperidol, QT prolongation, and sudden death: what is the evidence?
Kao LW; Kirk MA; Evers SJ; Rosenfeld SH
Ann Emerg Med; 2003 Apr; 41(4):546-58. PubMed ID: 12658255
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine.
Letsas KP; Sideris A; Kounas SP; Efremidis M; Korantzopoulos P; Kardaras F
Int J Cardiol; 2006 May; 109(2):273-4. PubMed ID: 15935493
[TBL] [Abstract][Full Text] [Related]
20. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
Ly T; Ruiz ME
Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]